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Surviving Myxedema Coma in a Patient with Previously Undiagnosed Hypothyroidism
Shadi Jarjous, M.D., Lehigh Valley Hospital, Allentown, Pennsylvania

Introduction
• Myxedema coma is a clinically diagnosed, rare,
life-threatening condition that is seen in less than
0.1 % of all cases of hypothyroidism.
• It is usually precipitated by metabolic-related
stressors that overwhelm the body’s compen
satory responses to hypothyroidism:
n 
Infection
n 
Medication
n 
Trauma
n 
Burn
n 
Bleeding
n 
Stroke
n 
Surgery
• Myxedema coma is
usually seen in older
women in the winter
months.

Case Description
History
• D. C. is a 59 years old Caucasian female, without
history of hypothyroidism, who presented to the
emergency department after her family noted mental
status changes.
• The patient has not seen a physician in decades.
• Her husband reported that months prior to admission,
the patient sustained an injury to her right foot after
stepping on a broken glass at home. The patient
declined to seek medical attention and treated it with
iodine peroxide.
• Over the past couple of months prior to admission,
she had progressively worsening gait dysfunction
secondary to foot pain from the non-healing wound.
• She developed non-pitting edema initially of the right
foot, which evolved to include the bilateral lower
extremities.
• The patient became confined to the couch, requiring
maximum assistance for ambulation.
• Her condition worsened during the week prior to
admission with cold intolerance, urinary retention,
occasional incontinence, hallucinations, slurred slow
speech and decreasing level of consciousness, in
addition to her chronic complains of fatigue, anorexia,
hair loss and depression.

Physical Exam
• On presentation, the patient had hypothermia,
bradycardia, hypotension, myxedematous face,
alopecia, ascites and Anasarca.
• She had a visible non-healing ulcer involving her
right foot.

Investigational studies
• Extensive laboratory and radiographic testing revealed
acute hypercapnic respiratory failure, pancytopenia
with bandemia, hyponatremia, hypokalemia, hypo
magnesemia, hyperlipidemia, transaminitis, CHF,
pneumonia, cerebral edema, pleural and pericardial
effusions, and mesenteric edema.
• TSH level was elevated at 96.33 uIU/ml with
T4 < 0.10 ng/dl.

Hospital course
• The patient was treated in the medical intensive care
unit where she required intubation for decreased level
of consciousness, increased work of breathing, and
hypoxia.
• She was warmed by an external warming blanket and
resuscitated with intravenous fluids followed by the
addition of multiple vasopressors.
• Treatment of the profound hypothyroidism started with
levothyroxine 250 mcg IV bolus initially followed by 100
mcg PO daily.
• She was started on antibiotics for presumptive septic
shock secondary to MSSA osteomyelitis of right 4th toe
and underwent open transmetatarsal amputation of the
toe with excisional debridement of right foot when she
was stabilized from a hemodynamic stand point.

Outcome
• The patient made an astonishing recovery during her
twenty day hospital stay and was discharged to a
skilled nursing facility for rehabilitation.

Discussion
• We report the successful treatment of a patient with
myxedema coma with levothyroxine administered via
an orogastric tube and supportive care in the medical
ICU.
• Reported cases of Myxedema coma are rare.
• Despite aggressive management, mortality rate still
approaches 40 %.
• Prompt recognition and treatment with thyroid
hormone combined with pulmonary and cardiovascular
support in an intensive care setting is essential for
survival.

